|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
|
|---|---|---|---|---|
| Cash flows from operating activities | ||||
| Net increase in net assets from operations | ||||
| Adjustments to reconcile net increase in net assets from operations to net cash (used in) provided by operating activities: | ||||
| Purchases and originations of investments | ||||
| Proceeds from sales and repayments of debt investments in portfolio companies | ||||
| Proceeds from sales and return of capital of equity investments in portfolio companies | ||||
| Proceeds from return of capital of investment in I-45 SLF LLC | ||||
| Payment of accreted original issue discounts | ||||
| Payment of accrued payment-in-kind interest | ||||
| Depreciation and amortization | ||||
| Net pension benefit | ||||
| Realized (gain) loss on investments before income tax | ||||
| Realized loss on extinguishment of debt | ||||
| Realized loss on disposal of fixed assets | ||||
| Net unrealized depreciation (appreciation) on investments before income tax | ||||
| Accretion of discounts on investments | ||||
| Payment-in-kind interest | ||||
| Share-based compensation expense | ||||
| Deferred income taxes | ||||
| Changes in other assets and liabilities: | ||||
| Increase in dividend and interest receivable | ||||
| Decrease (increase) in escrow receivables | ||||
| (Increase) decrease in tax receivable | ||||
| Decrease (increase) in other receivables | ||||
| Decrease (increase) in other assets | ||||
| (Decrease) increase in taxes payable | ||||
| (Decrease) increase in other liabilities | ||||
| Net cash (used in) provided by operating activities | ||||
| Cash flows from investing activities | ||||
| Acquisition of fixed assets | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities | ||||
| Proceeds from common stock offering | ||||
| Equity offering costs paid | ||||
| Borrowings under Credit Facilities | ||||
| Repayments of Credit Facilities | ||||
| Debt issuance costs paid | ||||
| Proceeds from issuance of SBA Debentures | ||||
| Proceeds from issuance of September 2030 Notes | ||||
| Proceeds from issuance of 2029 Convertible Notes | ||||
| Proceeds from issuance of August 2028 Notes | ||||
| October 2026 Notes | ||||
| August 2028 Notes | ||||
| Total proceeds from issuance of August 2028 Notes | ||||
| Redemption of notes | ||||
| January 2026 Notes | ||||
| October 2026 Notes | ||||
| August 2028 Notes | ||||
| October 2024 Notes | ||||
| Total redemption of notes | ||||
| Payment for debt extinguishment costs | ||||
| Dividends to shareholders | ||||
| Common stock withheld for payroll taxes upon vesting of restricted stock | ||||
| Net cash provided by financing activities | ||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | ||||
| Cash, cash equivalents and restricted cash at beginning of period | ||||
| Cash, cash equivalents and restricted cash at end of period | ||||
| Supplemental cash flow disclosures: | ||||
| Cash paid for income taxes | ||||
| Cash paid for interest | ||||
| Distributions in kind received | ||||
| Total cash, cash equivalents and restricted cash presented in the Consolidated Statements of Cash Flows | ||||
| Cash and cash equivalents | ||||
| Restricted cash | ||||
Loading...
